205 related articles for article (PubMed ID: 6603592)
1. Myasthenia gravis. Immunological studies in a young child treated with thymectomy and immunosuppressive drugs.
Bjerre I; Hallberg A
Neuropediatrics; 1983 May; 14(2):106-9. PubMed ID: 6603592
[TBL] [Abstract][Full Text] [Related]
2. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
4. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
Tindall RS
Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
[No Abstract] [Full Text] [Related]
5. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
6. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
7. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
[TBL] [Abstract][Full Text] [Related]
8. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis (second of two parts).
Drachman DB
N Engl J Med; 1978 Jan; 298(4):186-93. PubMed ID: 339085
[No Abstract] [Full Text] [Related]
11. In vitro T-cell dependent B-cell activity in myasthenia gravis.
Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
[TBL] [Abstract][Full Text] [Related]
12. [Plasma exchange in myasthenia gravis].
Redeker M; Meyer-Wahl L
Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
[No Abstract] [Full Text] [Related]
13. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
[TBL] [Abstract][Full Text] [Related]
14. [Juvenile myasthenia gravis].
Ohno K; Sahashi K
Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
[No Abstract] [Full Text] [Related]
15. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
Denizot M; Fulpius BW; Cox JN; Ferrier PE
Helv Paediatr Acta; 1979 Sep; 34(4):375-80. PubMed ID: 521303
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.
Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Satomura Y; Arimura K; Osame M; Hattori T;
J Neurol Sci; 2004 Sep; 224(1-2):43-7. PubMed ID: 15450770
[TBL] [Abstract][Full Text] [Related]
19. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
[No Abstract] [Full Text] [Related]
20. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
